◀ Back to MAPK9
FGF14 — MAPK9
Text-mined interactions from Literome
Viñals et al., Mol Cell Biol 1999
:
p42/p44
MAPK activation by fetal calf serum or
fibroblast growth factor was restrained in confluent cells in comparison with the activity found in sparse cells
Klingenberg et al., J Biol Chem 1999
:
The results indicate that while the mutations strongly affect the ability of the growth factor to bind to heparin, they do not affect much the binding to the specific
FGF receptors,
activation of
mitogen activated protein kinase or transport of the growth factor to the nucleus
Fabbro et al., Pharmacol Ther 1999
:
CGP 41251 inhibits reversibly intracellular PKC activity, induction of c-fos and the corresponding activation of the
mitogen activated protein kinase induced by either tumor promoting phorbol esters, platelet derived growth factor, or basic
fibroblast growth factor , but not by the epidermal growth factor
O'Reilly et al., Mol Cell Biol 2000
:
Previously, using a dominant negative mutant approach, we showed that the protein-tyrosine phosphatase SHP-2 is necessary for
FGF induced
MAPK activation , mesoderm induction, and elongation of animal caps
Wu et al., J Biol Chem 2000
:
MAPK/ERK kinase inhibition
diminished VEGF-,
FGF- , and EGF promoted thymidine incorporation into DNA
Wang et al., Oncogene 2000
(Bone Neoplasms...) :
Specific inhibition of
FGF induced
MAPK activation by the receptor-like protein tyrosine phosphatase LAR ... We found that although both EGF and FGF induce activation of mitogen activated protein kinase ( MAPK ), LAR only inhibits
FGF induced
MAPK activation ... The specific effect of LAR on
FGF induced
MAPK activation appeared to be mediated by specific inhibition of the phosphorylation of two signal transducers that act downstream of the FGF receptor, FRS2 and a 180 kDa protein, and by prevention of their interaction with the adaptor protein GRB2
Cohen et al., J Neurosci Res 2000
:
Further,
FGF-9 stimulated mitogen associated protein kinase (
MAPK ) phosphorylation
Curran et al., Dev Biol 2000
:
Activation of MAPK in young embryos is abolished by injection of a dominant negative FGF receptor ( XFD ) RNA, suggesting that
MAPK is
activated primarily by
FGF in this context ... Inhibition of
FGF signaling does not
block posterior neural gene expression ( HoxB9 ) or activation of
MAPK ; however, inhibition of FGF signaling does cause a statistically significant decrease in the level of activated MAPK
Kamimura et al., J Biol Chem 2001
:
We also show that
FGF dependent
mitogen activated protein kinase activation is significantly reduced in dHS6ST double stranded RNA injected embryos
Hadari et al., Proc Natl Acad Sci U S A 2001
:
Experiments with FRS2 alpha-deficient fibroblasts demonstrate that FRS2 alpha plays a critical role in
FGF induced
mitogen activated protein ( MAP ) kinase stimulation, phosphatidylinositol-3 (PI-3) kinase activation, chemotactic response, and cell proliferation
Mehta et al., Oncogene 2001
(Prostatic Neoplasms) :
In vitro expression of the transcription factors Elk-1 and MEF2A ( substrates for ERK1/2 and p38, respectively ) for functional quantification, confirmed the pattern of
FGF induced
MAPK activations in COS-7 cells
Fürthauer et al., Nat Cell Biol 2002
(MAP Kinase Signaling System) :
Sef is a feedback induced antagonist of
Ras/MAPK mediated
FGF signalling ... Here we show that in zebrafish, Sef functions as a feedback induced antagonist of
Ras/Raf/MEK/MAPK mediated
FGF signalling
Maher et al., Oncogene 2002
(MAP Kinase Signaling System) :
TPA treatment has little or no effect on
FGF receptor activation but specifically
inhibits the activation of p38
MAPK but not other downstream signaling pathways implicated in cell proliferation
Park et al., Mol Cell Biol 2002
:
Moreover,
FGF induced activation of
mitogen activated protein ( MAP ) kinase is also inhibited by XLPTP1 morpholino antisense oligonucleotides ; however, introduction of RNA encoding XLPTP1 is able to rescue morphological and biochemical effects of antisense inhibition
Stevens et al., Mol Endocrinol 2003
:
Fibroblast growth factor 2 (FGF2) stimulated
MAPK in osteoblasts, and pretreatment with T3 for 6 h
induced a more rapid response to
FGF that was increased in magnitude by 2- to 3-fold
Jackson et al., Mol Endocrinol 2003
(MAP Kinase Signaling System...) :
FGF induction of rPRL transcription is independent of Ras, but
mediated by a protein kinase C-delta (PKCdelta) dependent activation of
MAPK ( ERK )
Bansal et al., J Neurosci Res 2003
:
Specific inhibitor of FGF receptor signaling
: FGF-2 mediated effects on proliferation, differentiation, and
MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells
Lai et al., Oncogene 2004
(Carcinoma, Squamous Cell...) :
Clonal lines of HSulf-1 expressing 012SCC attenuated the activation of ERK/mitogen activated protein kinase ( MAPK ) signaling
mediated by
fibroblast growth factor ( FGF-2 ) and both
ERK/MAPK and Akt signaling mediated by hepatocyte growth factor (HGF)
De Robertis et al., Annu Rev Cell Dev Biol 2004
:
Neural induction by anti-BMPs such as Chordin requires
mitogen activated protein kinase ( MAPK ) activation
mediated by
FGF and IGF
Ishibe et al., Clin Cancer Res 2005
(Sarcoma, Synovial) :
FGF signals in synovial sarcoma
induced the phosphorylation of extracellular signal regulated kinase ( ERK1/2 ) and
p38MAPK but not c-Jun NH2-terminal kinase
Hoch et al., Development 2006
(Embryo Loss...) :
However, the mutant receptor is able to drive Fgfr1 functions during gastrulation and somitogenesis, and drives normal
MAPK responses to
Fgf
Cuevas et al., J Cell Mol Med 2006
(Glioma) :
Accordingly, it should be expected this new synthetic
FGF inhibitor to
affect the activation levels of
MAPK
Easton et al., J Neurochem 2006
(Neuroblastoma) :
In addition to Shc,
fibroblast growth factor receptor substrate 2 (FRS2) is
required for the BDNF induced activation of
MAPK
Antoine et al., Biochem Biophys Res Commun 2006
:
Interestingly,
FGF2 , which is mitogenic on endothelial cells and hepatocytes
stimulates a sustained
MAPK activation in both cell types, while FGF18 causes a short transient activation of the MAPK pathway in endothelial cells but a sustained activation in hepatocytes
Smith et al., FEBS Lett 2006
(MAP Kinase Signaling System) :
Negative feedback predominates over cross-regulation to control ERK
MAPK activity in
response to
FGF signalling in embryos
Eiselleova et al., Stem Cells 2009
:
In addition,
FGF-2 signaling via FGFR2
activated MAPK kinase/extracellular signal regulated kinase and AKT kinases, protected hESC from stress induced cell death, and increased hESC adhesion and cloning efficiency
Zhu et al., Cell communication and signaling : CCS 2010
:
We have previously shown in rat mammary fibroblasts that in cells deficient in sulfation, and so in HS co-receptor,
FGF-2 can only
stimulate a transient phosphorylation of p42/44
MAPK and so can not stimulate DNA synthesis
Dai et al., Clinical lymphoma, myeloma & leukemia 2011
(MAP Kinase Signaling System...) :
Overexpression of MPS-1 resulted in decreased
fibroblast growth factor ( FGF2 ) receptor 3 and
impaired endogenous
MAPK/ErK signaling
Shavkunov et al., Assay Drug Dev Technol 2012
(Ion Channel Gating) :
Through a platform of counter screenings, we show that the
p38/MAPK inhibitor, PD169316, and the I?B kinase inhibitor, BAY 11-7082,
reduce the
FGF14 : Nav1.6 C-tail complementation, highlighting a potential role of the p38MAPK and the I?B/NF?B pathways in controlling neuronal excitability through protein-protein interactions
Hwangpo et al., J Biol Chem 2012
(MAP Kinase Signaling System) :
Overexpression of GRIN potentiated
FGF activation of
MAPK and decreased tyrosine phosphorylation of Sprouty2 ... Decreased expression of GRIN both diminished
FGF activation of
MAPK and blocked CB1R attenuation of MAPK activation
Harding et al., Development 2012
:
We demonstrate that activation of
Fgf receptor ( Fgfr ) induces intracellular
Ras-MAPK , which is required for apical constriction and rosette formation in the pLLp
Watt et al., Arthritis Rheum 2013
:
In contrast,
FGF signaling blockade with PD173074
reduced all
MAPK and IKK activation by ~50 % and inhibited a different subset of genes but had no effect on Src-like signaling
Lorget et al., Am J Hum Genet 2012
(Achondroplasia...) :
In ACH human growth-plate chondrocytes, we demonstrated a decrease in the phosphorylation of extracellular-signal regulated kinases 1 and 2, confirming that this CNP analog inhibits
fibroblast-growth-factor mediated
MAPK activation
Tang et al., Cell 1995
:
In ectodermal explants, delta P blocks fibroblast growth factor ( FGF ) - and activin mediated induction of mesoderm and
FGF induced
mitogen activated protein ( MAP ) kinase activation
Chabre et al., Endocrinology 1995
:
Indeed, ACTH completely blocks ( IC50 = 0.01 nM ) the
stimulation of
MAPK by AII,
fibroblast growth factor-2 , or TPA
Hartley et al., Dev Biol 1994
:
MAP kinase ( MAPK ) is activated in animal cap explants from Xenopus embryos in
response to mesoderm induction by
FGF ... However, activin can potentiate the
activation of
MAPK by
FGF as early as 1 min after administration
Kornmann et al., J Clin Invest 1998
(Pancreatic Neoplasms) :
EGF,
FGF-2 , and IGF-I
enhanced mitogen activated protein kinase activity in antisense expressing clones, but failed to stimulate their proliferation
Mehta et al., J Biol Chem 1998
:
Incubation of the NR cells with either form of FGF-1 resulted in its binding to cell-surface
FGF receptors,
activation of
mitogen activated protein ( MAP ) kinase , and induction of c-fos and c-myc
Padua et al., J Mol Cell Cardiol 1998
(Reperfusion Injury) :
Finally,
FGF-2 induced increased active
MAPK at sarcolemmal as well as cytosolic sites